Quick Search:

is currently disabled due to reindexing of the ZORA database. Please use Advanced Search.
uzh logo
Browse by:

Zurich Open Repository and Archive 

Permanent URL to this publication: http://dx.doi.org/10.5167/uzh-48847

Karpova, M B; Barysch, M J; Zipser, M C; Schönewolf, N; French, L E; Dummer, R (2011). Changing pathology with changing drugs: skin cancer. Pathobiology, 78(2):61-75.

[img]Published Version
PDF - Registered users only


Today skin cancer is mainly treated by surgical interventions. New findings concerning molecular biology and the signaling pathways in epithelial skin cancers such as basal cell carcinoma, squamous cell carcinoma or melanoma, and mesenchymal skin cancers such as angiosarcoma and dermatofibrosarcoma protuberans (DFSP) have identified new molecular targets for a systemic or local treatment approach. For DFSP there is an opportunity already today to reduce the intensity of surgical procedures by pretreatment with targeted therapy. This article highlights important aspects in several skin cancer types.

Item Type:Journal Article, refereed, original work
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Dermatology Clinic
DDC:610 Medicine & health
Deposited On:02 Aug 2011 08:27
Last Modified:28 Nov 2013 00:46
Publisher DOI:10.1159/000314576
PubMed ID:21677470
Citations:Web of Science®
Google Scholar™

Users (please log in): suggest update or correction for this item

Repository Staff Only: item control page